117 related articles for article (PubMed ID: 25020038)
1. Potential use of fucose-appended dendrimer/α-cyclodextrin conjugates as NF-κB decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
Akao C; Tanaka T; Onodera R; Ohyama A; Sato N; Motoyama K; Higashi T; Arima H
J Control Release; 2014 Nov; 193():35-41. PubMed ID: 25020038
[TBL] [Abstract][Full Text] [Related]
2. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
[TBL] [Abstract][Full Text] [Related]
3. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
Arima H; Motoyama K; Higashi T
Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
[TBL] [Abstract][Full Text] [Related]
4. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
Higuchi Y; Kawakami S; Yamashita F; Hashida M
Biomaterials; 2007 Jan; 28(3):532-9. PubMed ID: 16982089
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
[TBL] [Abstract][Full Text] [Related]
7. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
[TBL] [Abstract][Full Text] [Related]
8. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
Lu JW; Wang H; Yan-Li J; Zhang C; Ning H; Li XY; Zhang H; Duan ZH; Zhao L; Wei W; Xu DX
J Hepatol; 2008 Mar; 48(3):442-52. PubMed ID: 18215436
[TBL] [Abstract][Full Text] [Related]
10. Effects of dendrimer/cyclodextrin conjugates as gene transfer carriers on nitric oxide production from macrophages.
Motoyama K; Sako A; Ibrahim Abu Hashim I; Higashi T; Arima H
J Pharm Pharmacol; 2016 May; 68(5):598-607. PubMed ID: 26076676
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
[TBL] [Abstract][Full Text] [Related]
12. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
Ohyama A; Higashi T; Motoyama K; Arima H
Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
[TBL] [Abstract][Full Text] [Related]
14. Potential protective effect of nuclear factor-κB decoy oligodeoxynucleotides on endotoxin-induced liver injury.
Li JD; Peng Y; Li Q; Xiao JW; Gong JP; Liu ZJ
Transplant Proc; 2011 Dec; 43(10):3613-7. PubMed ID: 22172814
[TBL] [Abstract][Full Text] [Related]
15. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
Goto T; Takeuchi S; Miura K; Ohshima S; Mikami K; Yoneyama K; Sato M; Shibuya T; Watanabe D; Kataoka E; Segawa D; Endo A; Sato W; Yoshino R; Watanabe S
Cytokine; 2006 Jan; 33(1):28-35. PubMed ID: 16413198
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of sugar-modified cationic liposome/NF-kappaB decoy complexes on adenovirus vector-induced innate immune responses.
Huang H; Sakurai F; Higuchi Y; Kawakami S; Hashida M; Kawabata K; Mizuguchi H
J Control Release; 2009 Jan; 133(2):139-45. PubMed ID: 18977256
[TBL] [Abstract][Full Text] [Related]
17. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo.
Anno T; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H
J Drug Target; 2012 Apr; 20(3):272-80. PubMed ID: 22201459
[TBL] [Abstract][Full Text] [Related]
18. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K
J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992
[TBL] [Abstract][Full Text] [Related]
20. Pseudoephedrine/ephedrine shows potent anti-inflammatory activity against TNF-α-mediated acute liver failure induced by lipopolysaccharide/D-galactosamine.
Wu Z; Kong X; Zhang T; Ye J; Fang Z; Yang X
Eur J Pharmacol; 2014 Feb; 724():112-21. PubMed ID: 24365491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
